Positive Psychology for Smoking Cessation
Positive Psychotherapy for Smoking Cessation: A Focus on Strengths to Improve Self-efficacy and Enable Successful Quitting Strategies
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Hampshire
-
Manchester, New Hampshire, United States, 03103
- The Mental Health Center of Greater Manchester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 21+;
- Serious Mental Illness (SMI) diagnosis;
- smoking ≥10 CPD;
- breath CO ≥10;
- desire to quit in the next month;
- willingness to use NRT daily;
- English speaking and literate to engage in the treatment.
Exclusion Criteria:
- legal guardian;
- active substance use disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Positive Recovery Smoking Cessation (Individual and Group)
The "Positive Recovery for Smoking" program is a 16-week treatment that focuses on the use of identifying signature character strengths and identifying, creating, and enjoying positive life events to facilitate recovery from smoking addiction. The first 4 individual sessions will focus on a self-evaluation of strengths and a focus on the individuals top 5 "signature strengths". The participants will then learn about how their signature strengths currently help them function and when and how they can use these strengths to recover from smoking. The group sessions will begin at 5 weeks (following 4 individual sessions) - sessions are structured to begin with a check-in where patients identify their most used signature strengths and take inventory of their smoking and cessation efforts from the past week. We will then support participants in their efforts to learn new ways to navigate positive recovery. |
Positive psychology-based individual treatment and groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Abstinence from Smoking
Time Frame: baseline to 16 weeks
|
At least 20% of participants will achieve abstinence (0 cigarettes per day and CO less than 6) at 16 weeks.
|
baseline to 16 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2202130-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.